RICHARD BRANDT: Open Payments
NPI 1861651754 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,353 in 170 payments from 19 companies in 2025. Trend: 2023 $2,963 · 2024 $5,669 · 2025 $3,353
Food & beverage: $3,155Education: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $473 |
| UCB, Inc. | 24 | $426 |
| Regeneron Healthcare Solutions, Inc. | 13 | $379 |
| Novartis Pharmaceuticals Corporation | 15 | $336 |
| Amgen Inc. | 11 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $223 |
| Janssen Biotech, Inc. | 8 | $202 |
| GENZYME CORPORATION | 8 | $191 |
| Lilly USA, LLC | 8 | $166 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 14 | $161 |
Products named: DUPIXENT, Bimzelx, OTEZLA, SKYRIZI, COSENTYX, TREMFYA, ILUMYA, Cabtreo.
Industry payments across TX — which companies pay providers there.
